{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:36:48Z","timestamp":1785393408605,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Topics in Companion Animal Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.tcam.2020.100461","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T04:24:39Z","timestamp":1593404679000},"page":"100461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Outcome of Canine Multicentric Lymphoma after Single or Divided Treatment with Cyclophosphamide in Multidrug Chemotherapy"],"prefix":"10.1016","volume":"41","author":[{"given":"Jih-Jong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Taiching","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2390-1632","authenticated-orcid":false,"given":"Shang-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcam.2020.100461_bib0001","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/vco.12009","article-title":"Risk factors for development of sterile haemorrhagic cystitis in canine lymphoma patients receiving oral cyclophosphamide: a case\u2013control study","volume":"12","author":"Gaeta","year":"2014","journal-title":"Vet Comp Oncol"},{"key":"10.1016\/j.tcam.2020.100461_bib0002","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2460\/javma.1986.188.11.1319","article-title":"Effects of cyclophosphamide in dogs and cats","volume":"188","author":"Stanton","year":"1986","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.tcam.2020.100461_bib0003","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/1097-0142(19880201)61:3<451::AID-CNCR2820610308>3.0.CO;2-G","article-title":"Cyclophosphamide\u2010induced hemorrhagic cystitis: a review of 100 patients","volume":"61","author":"Stillwell","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.tcam.2020.100461_bib0004","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0277-5379(82)90143-2","article-title":"Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention-III. Profile of action of sodium 2-mercaptoethane sulfonate (Mesna)","volume":"18","author":"Brock","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.tcam.2020.100461_bib0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/vr.101574","article-title":"Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs\u2013a retrospective study","volume":"174","author":"Laberke","year":"2014","journal-title":"Vet Rec"},{"key":"10.1016\/j.tcam.2020.100461_bib0006","first-page":"704","article-title":"Evaluation of a 6\u2010month chemotherapy protocol with no maintenance therapy for dogs with lymphoma","volume":"16","author":"Garrett","year":"2002","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.tcam.2020.100461_bib0007","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2460\/javma.243.7.1025","article-title":"Incidence of sterile hemorrhagic cystitis in dogs receiving cyclophosphamide orally for three days without concurrent furosemide as part of a chemotherapeutic treatment for lymphoma: 57 cases (2007\u20132012)","volume":"243","author":"Best","year":"2013","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.tcam.2020.100461_bib0008","series-title":"TNM Classification of Tumours in Domestic Animals","author":"Owen","year":"1980"},{"key":"10.1016\/j.tcam.2020.100461_bib0009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1476-5829.2009.00200.x","article-title":"Response evaluation criteria for peripheral nodal lymphoma in dogs (v1. 0)\u2013a Veterinary Cooperative Oncology Group (VCOG) consensus document","volume":"8","author":"Vail","year":"2010","journal-title":"Vet Comp Oncol"},{"key":"10.1016\/j.tcam.2020.100461_bib0010","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2460\/javma.2003.222.1388","article-title":"Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990\u20131996)","volume":"222","author":"Charney","year":"2003","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.tcam.2020.100461_bib0011","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/vr.g1887","article-title":"Reducing the side effects of cyclophosphamide chemotherapy in dogs","volume":"174","author":"Dobson","year":"2014","journal-title":"Vet Rec"},{"key":"10.1016\/j.tcam.2020.100461_bib0012","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM197102112840602","article-title":"Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy","volume":"284","author":"Johnson","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcam.2020.100461_bib0013","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1939-1676.2011.0730.x","article-title":"Pharmacokinetics of cyclophosphamide after oral and intravenous administration to dogs with lymphoma","volume":"25","author":"Warry","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.tcam.2020.100461_bib0014","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tvjl.2016.04.013","article-title":"Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: is cyclophosphamide the weakest link?","volume":"213","author":"Wang","year":"2016","journal-title":"Vet J"},{"key":"10.1016\/j.tcam.2020.100461_bib0015","first-page":"1263","article-title":"Tolerance to antineoplastic agents in children and adults","volume":"69","author":"Marsoni","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.tcam.2020.100461_bib0016","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1464-410X.2009.09132.x","article-title":"The management of cyclophosphamide\u2010induced haematuria","volume":"105","author":"Mukhtar","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.tcam.2020.100461_bib0017","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0003-4819-78-6-861","article-title":"Water intoxication in man after cyclophosphamide therapy: time course and relation to drug activation","volume":"78","author":"DeFronzo","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tcam.2020.100461_bib0018","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1939-1676.2009.0357.x","article-title":"Combination chemotherapy with continuous l\u2010asparaginase, lomustine, and prednisone for relapsed canine lymphoma","volume":"23","author":"Saba","year":"2009","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.tcam.2020.100461_bib0019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3747\/co.v16i2.420","article-title":"Metronomic chemotherapy: changing the paradigm that more is better","volume":"16","author":"Scharovsky","year":"2009","journal-title":"Curr oncol"}],"container-title":["Topics in Companion Animal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1938973620300593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1938973620300593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:39:38Z","timestamp":1761849578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1938973620300593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":19,"alternative-id":["S1938973620300593"],"URL":"https:\/\/doi.org\/10.1016\/j.tcam.2020.100461","relation":{},"ISSN":["1938-9736"],"issn-type":[{"value":"1938-9736","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of Canine Multicentric Lymphoma after Single or Divided Treatment with Cyclophosphamide in Multidrug Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Topics in Companion Animal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcam.2020.100461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100461"}}